AU2001234088A1 - TNF-alpha inhibitors - Google Patents

TNF-alpha inhibitors

Info

Publication number: AU2001234088A1
Authority: AU; Australia
Prior art keywords: tnf; alpha inhibitors; inhibitors; alpha
Prior art date: 2000-02-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001234088A

Other versions

AU2001234088B2 (en

Inventor

Kazuaki Ikeya

Takahito Kitayoshi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Takeda Pharmaceutical Co Ltd

Original Assignee

Takeda Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-18

Filing date

2001-02-15

Publication date

2001-11-08

2001-02-15 Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd

2001-02-15 Priority claimed from PCT/JP2001/001069 external-priority patent/WO2001060362A1/en

2001-11-08 Publication of AU2001234088A1 publication Critical patent/AU2001234088A1/en

2004-11-11 Assigned to TAKEDA PHARMACEUTICAL COMPANY LIMITED reassignment TAKEDA PHARMACEUTICAL COMPANY LIMITED Amend patent request/document other than specification (104) Assignors: TAKEDA CHEMICAL INDUSTRIES, LTD.

2005-12-01 Application granted granted Critical

2005-12-01 Publication of AU2001234088B2 publication Critical patent/AU2001234088B2/en

2021-02-15 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2001234088A 2000-02-18 2001-02-15 Tnf-alpha inhibitors Ceased AU2001234088B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000-46828		2000-02-18
JP2000046828		2000-02-18
PCT/JP2001/001069 WO2001060362A1 (en)	2000-02-18	2001-02-15	TNF-α INHIBITORS

Publications (2)

Publication Number	Publication Date
AU2001234088A1 true AU2001234088A1 (en)	2001-11-08
AU2001234088B2 AU2001234088B2 (en)	2005-12-01

Family

ID=18569174

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU3408801A Withdrawn AU3408801A (en)	2000-02-18	2001-02-15	Tnf-alpha inhibitors
AU2001234088A Ceased AU2001234088B2 (en)	2000-02-18	2001-02-15	Tnf-alpha inhibitors

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU3408801A Withdrawn AU3408801A (en)	2000-02-18	2001-02-15	Tnf-alpha inhibitors

Country Status (10)

Country	Link
US (1)	US6833381B2 (en)
EP (1)	EP1262180A4 (en)
KR (1)	KR20030016229A (en)
CN (1)	CN1404390A (en)
AU (2)	AU3408801A (en)
CA (1)	CA2400124C (en)
HU (1)	HUP0301057A3 (en)
NO (1)	NO20023913L (en)
PL (1)	PL356422A1 (en)
WO (1)	WO2001060362A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100224601B1 (en) *	1997-05-13	1999-10-15	윤종용	The automatic feeder of complex image forming apparatus
AU2002210925A1 (en) *	2000-10-25	2002-05-06	Takeda Chemical Industries Ltd.	Preventives/remedies for portal hypertension
US20040097565A1 (en) *	2001-01-29	2004-05-20	Terashita Zen-Ichi	Analgesic and antiinflammatory drugs
BR0207297A (en)	2001-02-15	2005-04-19	King Pharmaceuticals Inc	Pharmaceutical composition in solid form and method of preparing a solid dosage form of a pharmaceutically active ingredient.
US6555581B1 (en)	2001-02-15	2003-04-29	Jones Pharma, Inc.	Levothyroxine compositions and methods
EP1390518B1 (en) *	2001-04-23	2004-10-06	Amaxa GmbH	Buffer solution for electroporation and a method comprising the use of the same
US7101569B2 (en)	2001-08-14	2006-09-05	Franz G Andrew	Methods of administering levothyroxine pharmaceutical compositions
US7812044B2 (en) *	2001-11-13	2010-10-12	Takeda Pharmaceutical Company Limited	Anticancer agents
JP4484427B2 (en) *	2001-12-03	2010-06-16	武田薬品工業株式会社	Insulin resistance improving agent
EP1452176A4 (en) *	2001-12-03	2009-01-21	Takeda Pharmaceutical	MEANS FOR IMPROVING INSULIN RESISTANCE
US7790681B2 (en) *	2002-12-17	2010-09-07	Amylin Pharmaceuticals, Inc.	Treatment of cardiac arrhythmias with GLP-1 receptor ligands
US20040209803A1 (en) *	2002-12-19	2004-10-21	Alain Baron	Compositions for the treatment and prevention of nephropathy
US7582662B2 (en) *	2002-12-27	2009-09-01	Takeda Pharmaceutical Company Limited	Body weight gain inhibitor
US20050201989A1 (en) *	2004-02-19	2005-09-15	St. Camillus Medical, Inc.	Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitors of tumor necrosis factor-alpha
US20050239842A1 (en) *	2004-04-23	2005-10-27	Zeldis Jerome B	Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of pulmonary hypertension
WO2005118166A2 (en) *	2004-06-04	2005-12-15	Teva Pharmaceutical Industries, Ltd.	Pharmaceutical composition containing irbesartan
US20050288272A1 (en) *	2004-06-23	2005-12-29	Solvay Pharmaceuticals Gmbh	Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
US20070054948A1 (en) *	2004-09-02	2007-03-08	Lilach Hedvati	Purification of olmesartan medoxomil
KR100953878B1 (en) *	2004-09-02	2010-04-22	테바 파마슈티컬 인더스트리즈 리미티드	Purification of Olmesaltan Medocsomil
US8506934B2 (en)	2005-04-29	2013-08-13	Robert I. Henkin	Methods for detection of biological substances
ATE526963T1 (en) *	2006-05-04	2011-10-15	Lek Pharmaceuticals	PHARMACEUTICAL COMPOSITION CONTAINING OLMESARTAN-MEDOXOMIL
WO2008095136A2 (en)	2007-01-31	2008-08-07	Henkin Robert I	Methods for detection of biological substances
CL2008000868A1 (en) *	2007-03-28	2008-10-10	Takeda Pharmaceutical	SOLID PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOSITE DERIVED FROM BENZIMIDAZOL AND A PH CONTROLLING AGENT; METHOD OF STABILIZATION AND IMPROVEMENT OF DISSOLUTION; USE OF A PH CONTROL AGENT.
US8580801B2 (en)	2008-07-23	2013-11-12	Robert I. Henkin	Phosphodiesterase inhibitor treatment
WO2010029576A2 (en)	2008-09-02	2010-03-18	Elder Pharmaceuticals Ltd.	Anti inflammatory compounds
TR201807207T4 (en) *	2012-06-11	2018-06-21	Ucb Biopharma Sprl	Tnf-alpha modulating benzimidazole compounds.
GB201321733D0 (en) *	2013-12-09	2014-01-22	Ucb Pharma Sa	Therapeutic agents
GB201321746D0 (en) *	2013-12-09	2014-01-22	Ucb Pharma Sa	Therapeutic agents
EP3108245B1 (en)	2014-02-18	2020-07-22	Robert I. Henkin	Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
GB201620948D0 (en) *	2016-12-09	2017-01-25	Ucb Biopharma Sprl	Therapeutic agents
WO2018201131A1 (en) *	2017-04-28	2018-11-01	Asana Biosciences, Llc	Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredient

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5196444A (en) *	1990-04-27	1993-03-23	Takeda Chemical Industries, Ltd.	1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5605919A (en) *	1993-02-26	1997-02-25	Takeda Chemical Industries, Ltd.	Treatment for viral diseases
CA2115985A1 (en) *	1993-02-25	1994-08-26	Kohei Nishikawa	Vascular hypertrophy suppressor
JP3810020B2 (en) *	1993-04-22	2006-08-16	武田薬品工業株式会社	Preventive or therapeutic agent for kidney disease
US5721263A (en) *	1993-06-07	1998-02-24	Takeda Chemical Industries, Ltd.	Pharmaceutical composition for angiotensin II-mediated diseases
US5824696A (en) *	1993-09-01	1998-10-20	Smithkline Beecham Corporation	Medicaments
DK0743852T3 (en) *	1994-02-08	2005-10-17	Novartis Ag	Treatment of normal pressure glaucoma with valsartan
SE9501881D0 (en) *	1995-05-19	1995-05-19	Astra Ab	New pharmacological use of AII receptor antagonists
JPH11509838A (en) *	1995-06-07	1999-08-31	ジー．ディー．サールアンドカンパニー	Combination therapy of spironolactone compounds and angiotensin II antagonists for treating congestive heart failure
EP0835106A4 (en) *	1995-06-30	1998-09-30	Merck & Co Inc	METHOD FOR TREATING KIDNEY DISEASES USING AN ACE INHIBITOR AND AII ANTAGONIST
SK283348B6 (en) *	1996-04-05	2003-06-03	Takeda Chemical Industries, Ltd.	Pharmaceutical combination containing a compound having angiotensin II and antagonistic activity
WO1998030216A1 (en) *	1997-01-10	1998-07-16	Merck & Co., Inc.	Use of angiotensin ii antagonists to treat symptomatic heart failure
CA2318778A1 (en) *	1998-02-25	1999-09-02	Merck & Co., Inc.	Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist
IL137979A0 (en) *	1998-03-04	2001-10-31	Takeda Chemical Industries Ltd	Production, release preparation for aii antagonist-sustained and use thereof
JP2000159671A (en) *	1998-12-01	2000-06-13	Takeda Chem Ind Ltd	Arterialization inhibitor

2001
- 2001-02-15 EP EP01906130A patent/EP1262180A4/en not_active Withdrawn
- 2001-02-15 PL PL01356422A patent/PL356422A1/en not_active Application Discontinuation
- 2001-02-15 AU AU3408801A patent/AU3408801A/en not_active Withdrawn
- 2001-02-15 CN CN01805019A patent/CN1404390A/en active Pending
- 2001-02-15 CA CA2400124A patent/CA2400124C/en not_active Expired - Fee Related
- 2001-02-15 KR KR1020027010709A patent/KR20030016229A/en not_active Ceased
- 2001-02-15 WO PCT/JP2001/001069 patent/WO2001060362A1/en not_active Ceased
- 2001-02-15 HU HU0301057A patent/HUP0301057A3/en unknown
- 2001-02-15 US US10/203,805 patent/US6833381B2/en not_active Expired - Fee Related
- 2001-02-15 AU AU2001234088A patent/AU2001234088B2/en not_active Ceased
2002
- 2002-08-16 NO NO20023913A patent/NO20023913L/en not_active Application Discontinuation

Publication	Publication Date	Title
AU2001234088A1 (en)	2001-11-08	TNF-alpha inhibitors
AU2001258771A1 (en)	2001-11-26	-secretase inhibitors
AU3408801A (en)	2001-08-27	Tnf-alpha inhibitors
AU2001260674A1 (en)	2002-02-28	TNF-alpha production inhibitors
AU2002219555A1 (en)	2003-01-23	VLA-4 Inhibitors
AU2001244399A1 (en)	2001-10-23	Gamma-secretase inhibitors
AU2001237041A1 (en)	2001-11-08	Kinase inhibitors
AU2001296961A1 (en)	2002-04-08	17-beta-hydroxysteroid dehydrogenase-ii inhibitors
AU4882101A (en)	2001-11-12	Mmp-12 inhibitors
AU2002211663A1 (en)	2002-04-22	Nf-$g(k)b inhibitors
AU2001247589A1 (en)	2001-10-03	Non-amidine containing protease inhibitors
AU2001285750A1 (en)	2002-03-14	Urokinase inhibitors
AU2001294557A1 (en)	2002-03-26	Thrombin inhibitors
AU5248800A (en)	2001-09-24	Fading inhibitors
AU2001236052A1 (en)	2001-11-29	Urease inhibitors
AU2002211662A1 (en)	2002-04-22	Nf-kappab inhibitors
AU2002222627A1 (en)	2002-06-24	Tak1 inhibitors
AU2001255090A1 (en)	2001-11-12	Cdk inhibitors having 3-hydroxychromen-4-one structure
AU2001220281A1 (en)	2002-05-27	Rollerboard for road-skiing
AU2001244562A1 (en)	2001-10-08	Neovascularization inhibitors
AU2001232245A1 (en)	2001-08-20	Tnf- alpha inhibitors
AU3235100A (en)	2000-09-04	Prothease inhibitors
AU2002224550A1 (en)	2002-02-05	Corrosion inhibitors
AU1588901A (en)	2001-06-06	Protease inhibitors
AU1474801A (en)	2001-06-06	Protease inhibitors